Bitte benutzen Sie diese Referenz, um auf diese Ressource zu verweisen: doi:10.22028/D291-43803
Volltext verfügbar? / Dokumentlieferung
Titel: Thermo-amplifier circuit in probiotic E. coli for stringently temperature-controlled release of a novel antibiotic
VerfasserIn: Dey, Sourik
Seyfert, Carsten E.
Fink-Straube, Claudia
Kany, Andreas M.
Müller, Rolf
Sankaran, Shrikrishnan
Sprache: Englisch
Verlag/Plattform: bioRxiv
Erscheinungsjahr: 2024
Freie Schlagwörter: Bacterial drug delivery
Probiotic
E. coli Nissle 1917
Darobactin
T7 RNA polymerase
Thermo-amplifier
Anti-bacterial
DDC-Sachgruppe: 570 Biowissenschaften, Biologie
Dokumenttyp: Sonstiges
Abstract: Peptide drugs have seen rapid advancement in biopharmaceutical development, with over 80 candidates approved globally. Despite their therapeutic potential, the clinical translation of peptide drugs is hampered by challenges in production yields and stability. Engineered bacterial therapeutics is a unique approach being explored to overcome these issues by using bacteria to produce and deliver therapeutic compounds at the body site of use. A key advantage of this technology is the possibility to control drug delivery within the body in real time using genetic switches. However, the performance of such genetic switches suffers when used to control drugs that require post-translational modifications or are toxic to the host. In this study, these challenges were experienced when attempting to establish a thermal switch for the production of a ribosomally synthesized and post-translationally modified peptide antibiotic, darobactin, in probiotic E. coli. These challenges were overcome by developing a thermo-amplifier circuit that combined the thermal-switch with a T7 RNA Polymerase and its promoter that overcame limitations imposed by the host transcriptional machinery due to its orthogonality to it. This circuit enabled production of pathogen-inhibitory levels of darobactin at 40°C while maintaining leakiness below the detection limit at 37°C. More impressively, the thermo-amplifier circuit sustained production beyond the thermal induction duration. Thus, raised temperature for 2 h was sufficient for the bacteria to produce pathogen-inhibitory levels of darobactin even in the physiologically relevant simulated conditions of the intestines that include bile salts and low nutrient levels.
DOI der Erstveröffentlichung: 10.1101/2024.02.13.579303
URL der Erstveröffentlichung: https://www.biorxiv.org/content/10.1101/2024.02.13.579303v2
Link zu diesem Datensatz: urn:nbn:de:bsz:291--ds-438030
hdl:20.500.11880/39211
http://dx.doi.org/10.22028/D291-43803
Datum des Eintrags: 17-Dez-2024
Bemerkung/Hinweis: Preprint
Fakultät: NT - Naturwissenschaftlich- Technische Fakultät
Fachrichtung: NT - Biowissenschaften
NT - Pharmazie
Professur: NT - Prof. Dr. Aránzazu del Campo
NT - Prof. Dr. Rolf Müller
Sammlung:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Dateien zu diesem Datensatz:
Es gibt keine Dateien zu dieser Ressource.


Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt.